SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-16-006867
Filing Date
2016-08-17
Accepted
2016-08-17 16:45:18
Documents
2
Period of Report
2016-08-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s103955_8k.htm 8-K 22489
2 EXHIBIT 99.1 s103955_ex99-1.htm EX-99.1 16816
  Complete submission text file 0001615774-16-006867.txt   40530
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 161839122
SIC: 2836 Biological Products, (No Diagnostic Substances)